France Faces Regulatory Hurdles Despite Overwhelming Support for Medical Cannabis
Despite 92% public support for medical cannabis, France faces regulatory delays that restrict new patient access and fuel debate challenges.
Despite 92% public support for medical cannabis, France faces regulatory delays that restrict new patient access and fuel debate challenges.
Despite 92% public support for medical cannabis, France faces regulatory delays that restrict new patient access and fuel debate challenges.